Application platform update brings enhancements for AI agent development, cryptography, runtime performance, and the C# and F# programming languages.

Microsoft’s fast-growing language for .NET may be poised to overtake Java in popularity for the first time, Tiobe said.

Python leads. C holds #2; C++ and Java dip as C# nears Java. Lower ranks shuffle — Perl returns, SQL at #10, and Go drops ...

In recent developments, Recursion Pharmaceuticals unveiled advances in its AI platform for drug discovery, forming collaborations with major pharmaceutical groups including Sanofi, Roche/Genentech, ...

We recently published 10 Big Names Beating Wall Street at its Own Game. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the best performers on Monday. Recursion Pharmaceuticals soared by 13.99 ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

Key data is currently not available. Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. *Data is provided by Barchart.com. Data reflects weightings calculated at ...

As promised, Microsoft today released .NET 10 after a 9 month development cycle that started with a first preview in February ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Microsoft's .NET 10 release highlights AI integration through the new Microsoft Agent Framework and related extensions, ...

Windows 11 has been in the news lately because of the sunsetting of Win 10, but a developer found the latest update to Microsoft's OS borked his .NET MAUI projects built with .NET 8. On Microsoft's ...